Nano-X (NNOX) CFO Reports 1,000-Share Purchase on Form 4
Rhea-AI Filing Summary
Daniel Ran, listed as the Chief Financial Officer of Nano-X Imaging Ltd. (NNOX), reported a direct purchase of ordinary shares on 09/05/2025. The Form 4 shows he acquired 1,000 ordinary shares at a price of $3.65 per share and, following the transaction, beneficially owned 6,950 ordinary shares in total. The filing indicates this is an individual filing by one reporting person and includes no derivative transactions.
Positive
- Insider acquisition recorded: Reporting person acquired 1,000 ordinary shares at $3.65 per share.
- Clear post-transaction ownership: Reporting person beneficially owned 6,950 ordinary shares after the acquisition.
- Complete Form 4 disclosure: Filing identifies reporting person, relationship (CFO), transaction details, and signature date.
Negative
- None.
Insights
TL;DR: Routine insider purchase reported: 1,000 ordinary shares bought at $3.65, increasing direct holdings to 6,950 shares.
This Form 4 documents a straightforward non-derivative acquisition by the issuer's CFO, Daniel Ran, on 09/05/2025. The transaction is recorded as a direct purchase (code P) for 1,000 ordinary shares at $3.65, with no associated derivative instruments disclosed. For investors tracking insider activity, this entry is a factual record of ownership change rather than a material corporate event.
TL;DR: Governance disclosure: CFO filed a timely Form 4 showing a modest direct purchase and no complex arrangements.
The filing is concise and contains the required elements: reporting person identity and address, relationship to issuer (CFO), transaction date, transaction code, number of shares acquired, price, and post-transaction beneficial ownership. There are no amendments, no derivatives, and the report is signed and dated. This represents routine compliance with Section 16 reporting obligations.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Ordinary shares | 1,000 | $3.65 | $4K |
Footnotes (1)
FAQ
What transaction did Daniel Ran report on the Form 4 for NNOX?
What is the reporting person's role at Nano-X Imaging (NNOX)?
Were any derivative securities reported in this Form 4 for NNOX?
When was the Form 4 transaction dated and signed?